SISCAPA Assay Technologies, Inc.
Biotechnology company · Washington, District of Columbia, United States
SISCAPA Assay Technologies, Inc. is a biotechnology company headquartered in Washington, District of Columbia, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2025.
SISCAPA Assay Technologies at a glance
What does SISCAPA Assay Technologies do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $2 million sold (2025).
Frequently asked questions about SISCAPA Assay Technologies
Where is SISCAPA Assay Technologies headquartered?
SISCAPA Assay Technologies, Inc. is headquartered in Washington, District of Columbia, United States.
What does SISCAPA Assay Technologies do?
SISCAPA Assay Technologies, Inc. is a biotechnology company.
When was SISCAPA Assay Technologies founded?
The earliest incorporation on record for SISCAPA Assay Technologies, Inc. is in 2011, according to public company registers.
Similar companies
- Vitakey Inc.Washington, District of Columbia, United States
- Floreo, Inc.Washington, District of Columbia, United States
- OncovirWashington, District of Columbia, United States
- Nanochon, Inc.Washington, District of Columbia, United States
- Media Rez LLCWashington, District of Columbia, United States
- Amelia Technologies LLCWashington, District of Columbia, United States
- Cyrano Therapeutics, Inc.Washington, District of Columbia, United States
- Neuroene Therapeutics IncWashington, District of Columbia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences